(Q43000027)

English

Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows

scientific article published on 17 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Japanese encephalitis virus

0 references

1 reference

based on heuristic

inferred from title

Japanese encephalitis

1 reference

based on heuristic

inferred from title

Tomohiko Takasaki

10

object named as

Tomohiko Takasaki

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

11

object named as

Ichiro Kurane

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Jun-ichi Imoto

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tomohiro Ishikawa

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Atsushi Yamanaka

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Misako Konishi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kenji Murakami

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tomoyuki Shibahara

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masanori Kubo

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chang-Kweng Lim

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masataka Hamano

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Haruhide Udagawa

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yoshihiro Mukuta

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Eiji Konishi

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

17 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

7373-7380

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ecology and geographical expansion of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

A cohort study to assess the new WHO Japanese encephalitis surveillance standards

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Japanese encephalitis for a reference to international travelers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Isolation and genetic analysis of Japanese encephalitis virus from a diseased horse in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Current use and development of vaccines for Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Current progress of DNA vaccine studies in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

DNA vaccines: ready for prime time?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Human clinical trials of plasmid DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

DNA vaccines and their applications in veterinary practice: current perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

From plasmids to protection: a review of DNA vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

DNA vaccines and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Immunization without needles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

DNA vaccines for flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Molecular epidemiological analyses of Japanese encephalitis virus isolates from swine in Japan from 2002 to 2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Naturally occurring immunoglobulin Mantibodies toToxoplasma gondiiin Japanese populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Education and research using experimental pigs in a medical school.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Antibody repertoire development in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Prospects for developing an effective particle-mediated DNA vaccine against influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Epidermal DNA vaccine for influenza is immunogenic in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.008

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.09.008

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43000027&oldid=1976331272"